Kessler Investment Group’s Gilead Sciences GILD Stock Holding History

Kessler Investment Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-49,804	Closed	-$6.94M	–	84
2026 Q1	$6.94M	Buy	+49,804	New	+$6.97M	3.29%	12
2018 Q3	–	Sell	-11,686	Closed	-$828K	–	162
2018 Q2	$828K	Sell	11,686 -345	-3%	-$24.4K	0.99%	40
2018 Q1	$907K	Sell	12,031 -1,213	-9%	-$96.4K	1.15%	37
2017 Q4	$949K	Buy	13,244 +165	+1%	+$12.5K	1.19%	31
2017 Q3	$1.06M	Buy	+13,079	New	+$1M	1.36%	23
2017 Q1	–	Sell	-44,726	Closed	-$3.2M	–	102
2016 Q4	$3.2M	Buy	+44,726	New	+$3.32M	3.85%	10
2014 Q1	–	Sell	-8,398	Closed	-$631K	–	101
2013 Q4	$631K	Sell	8,398 -2,086	-20%	-$145K	1.17%	41
2013 Q3	$659K	Sell	10,484 -678	-6%	-$40.5K	1.8%	21
2013 Q2	$572K	Buy	+11,162	New	+$582K	1.66%	23

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kessler Investment Group's GILD Position: Q2 2026 in Review

Kessler Investment Group sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 49,804 shares — an estimated $6.94M sold.

Kessler Investment Group first reported a position in GILD in Q2 2013 and held it in 9 quarters. The position peaked at $6.94M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Kessler Investment Group reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Kessler Investment Group sold 49,804 Gilead Sciences shares in Q2 2026, an estimated $6.94M.
Kessler Investment Group first reported a position in Gilead Sciences in Q2 2013 and held it in 9 quarters.
Kessler Investment Group's Gilead Sciences position peaked at $6.94M in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kessler Investment Group's 13F filing for Q2 2026, filed 13 Jul 2026.